Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3875979

CC#CCn1c(=O)n(CCc2ccccc2)c2ncnc(N3CCNCC3)c21.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 13/20 0.47
FAP Q12884 5/20 0.41
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C9 P11712 3/20 0.40
HPGD P15428 2/20 0.40
CASP1 P29466 2/20 0.40
CASP7 P55210 1/20 0.40
USP2 O75604 2/20 0.40
CYP2C19 P33261 2/20 0.40
DPP9 Q86TI2 1/20 0.39
MAPK1 P28482 2/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
ABCC1 P33527 2/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13867010 0.93 DPP4 (0.53) DPP4FAPALDH1A1HSD17B10CYP1A2
Trifluoroacetic Acid SCHEMBL3874210 0.88 DPP4 (0.39) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3881735 0.88 DPP4 (0.48) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3887064 0.87 DPP4 (0.50) DPP4FAPALDH1A1HSD17B10CYP1A2
Trifluoroacetic Acid SCHEMBL3874248 0.86 DPP4 (0.43) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3877720 0.85 DPP4 (0.39) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3874829 0.85 DPP4 (0.38) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3873547 0.85 DPP4 (0.38) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3884141 0.85 DPP4 (0.44) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3877001 0.84 DPP4 (0.49) DPP4FAPDPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524847-B2 Fused 1,3-dihydro-imidazole ring compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-04-28 US disclosed
US-20060111362-A1 1,3-Dihydroimidazole ring compound EISAI CO., LTD. (JP) 2006-05-25 US disclosed
EP-1568699-A1 1,3-DIHYDROIMIDAZOLE FUSED-RING COMPOUND Eisai Co., Ltd. (JP) 2005-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111362-A1 1,3-Dihydroimidazole ring compound NR2C2, NR0B2, DPP4 DPP4 3/4885FAP 4451/4885ALDH1A1 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.